Literature DB >> 32006482

Ocular Complications in School-Age Children and Adolescents after Allogeneic Bone Marrow Transplantation.

Mary Ellen Hoehn1, Robert Vestal2, Julie Calderwood3, Edwin Gannon2, Brittany Cook2, Richard Rochester4, Christine Hartford4, Brandon Triplett4, Anusha Sunkara5, Guolian Kang5, R Christopher Walton2.   

Abstract

PURPOSE: To determine the ocular complications in school-age children and adolescents surviving at least 1 year following allogeneic bone marrow transplantation.
DESIGN: Retrospective cohort study.
METHODS: In this institutional study, 162 patients (7-18 years old) met our inclusion criteria with a mean age of 13.4 years at bone marrow transplantation. Follow-up ranged from 13 months to 12 years (mean 4 years; median 3.2 years). Patient charts were screened for cataract formation, dry eye, and other anterior and posterior segment diseases.
RESULTS: Cataract formation was noted in 57 patients. Univariate analysis showed that fractionated total body irradiation, race, and use of cytarabine significantly increased the incidence of cataract formation (P < 0.05). Multivariate analysis of significant variables showed that total body irradiation was a risk factor for cataract formation. Of the 57 patients (97 eyes) who developed cataracts after bone marrow transplantation, 4 patients (6 eyes) required cataract surgery. After surgery, all patients had visual acuities of 20/20 to 20/25. Of the 162 patients, 51 developed dry eyes. Univariate analysis showed that age at transplantation; steroid use, chronic graft-versus-host disease; use of fludarabine, melphalan, and thiotepa; and receiving no pre-transplantation conditioning regimen prior to bone marrow transplant significantly increased the risk of dry eye syndrome (P < 0.05). In multivariate analysis, chronic graft-versus-host disease was a significant risk factor for dry eye syndrome.
CONCLUSIONS: Due to the high incidence of cataract formation and dry eye disease in this population, this study proposes these patients be screened using examinations by a pediatric or general ophthalmologist at least every year.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 32006482      PMCID: PMC7419076          DOI: 10.1016/j.ajo.2020.01.025

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  18 in total

1.  Ocular complications in a young pediatric population following bone marrow transplantation.

Authors:  Mary Ellen Hoehn; Julie Calderwood; Edwin Gannon; Brittany Cook; Richard Rochester; Christine Hartford; Brandon Triplett; Anusha Sunkara; Guolian Kang; R Christopher Walton
Journal:  J AAPOS       Date:  2018-01-05       Impact factor: 1.220

2.  Incidence, risk factors, and clinical outcomes of cataracts following hematopoietic stem cell transplantation.

Authors:  Yuho Najima; Kazuhiko Kakihana; Kazuteru Ohashi; Narumichi Yamamoto; Takeshi Kobayashi; Takuya Yamashita; Hisashi Sakamaki; Hideki Akiyama
Journal:  Am J Hematol       Date:  2011-04-20       Impact factor: 10.047

3.  The eye in bone marrow transplantation. III. Conjunctival graft-vs-host disease.

Authors:  D A Jabs; J Wingard; W R Green; E R Farmer; G Vogelsang; R Saral
Journal:  Arch Ophthalmol       Date:  1989-09

4.  The eye in bone marrow transplantation. I. Clinical study.

Authors:  L W Hirst; D A Jabs; P J Tutschka; W R Green; G W Santos
Journal:  Arch Ophthalmol       Date:  1983-04

5.  Cataracts after total body irradiation and marrow transplantation: a sparing effect of dose fractionation.

Authors:  H J Deeg; N Flournoy; K M Sullivan; K Sheehan; C D Buckner; J E Sanders; R Storb; R P Witherspoon; E D Thomas
Journal:  Int J Radiat Oncol Biol Phys       Date:  1984-07       Impact factor: 7.038

Review 6.  Late ocular complications after bone marrow transplantation.

Authors:  A Tichelli
Journal:  Nouv Rev Fr Hematol       Date:  1994

7.  Ocular complications of bone marrow transplantation.

Authors:  L C Bray; P J Carey; S J Proctor; R G Evans; P J Hamilton
Journal:  Br J Ophthalmol       Date:  1991-10       Impact factor: 4.638

8.  The eye in bone marrow transplantation. VI. Retinal complications.

Authors:  N M Coskuncan; D A Jabs; J P Dunn; J A Haller; W R Green; G B Vogelsang; G W Santos
Journal:  Arch Ophthalmol       Date:  1994-03

9.  Topical corticosteroid therapy for corneal toxicity from systemically administered cytarabine.

Authors:  J H Lass; H M Lazarus; M D Reed; R H Herzig
Journal:  Am J Ophthalmol       Date:  1982-11       Impact factor: 5.258

10.  Ocular complications in high-dose chemoradiotherapy and marrow transplantation.

Authors:  M K Jack; J D Hicks
Journal:  Ann Ophthalmol       Date:  1981-06
View more
  1 in total

1.  Long-term clinical outcomes and predictive factors in patients with chronic ocular graft-versus-host disease.

Authors:  Hyeon-Jeong Yoon; Ga-Young Song; Kyung Chul Yoon
Journal:  Sci Rep       Date:  2022-07-29       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.